Department of Obstetrics and Gynaecology, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran.
Arch Gynecol Obstet. 2010 Apr;281(4):623-6. doi: 10.1007/s00404-009-1148-3. Epub 2009 Jun 12.
To our knowledge, there is no report regarding adenosine deaminase activity (ADA) in gestational diabetes mellitus (GDM). The aim of the present study was to investigate the level of serum ADA activity in normal pregnancy, GDM and normal non-pregnant women.
The serum catalytic concentration of ADA was measured in samples of 20 GDM, 40 normal pregnant and 20 non-pregnant healthy women.
Adenosine deaminase activity was significantly higher in GDM (24.30 +/- 8.04 IU/L) and pregnant women (23.88 +/- 8.66 IU/L) than those of normal non-pregnant individuals (11.85 +/- 3.23 IU/L) (P < 0.0001), but the ADA level was not significantly different from GDM and normal pregnant women (P = 0.97).
Adenosine deaminase activity was significantly higher in GDM and pregnant individuals than normal group in this study. Previous reports in this field are contentious; therefore, ADA activity could be regulated in different population by immunologic and genetic factors.
据我们所知,目前尚无关于妊娠期糖尿病(GDM)中腺苷脱氨酶活性(ADA)的报道。本研究旨在探讨正常妊娠、GDM 和正常非妊娠妇女血清 ADA 活性水平。
检测 20 例 GDM、40 例正常妊娠和 20 例非妊娠健康妇女的血清 ADA 催化浓度。
GDM(24.30±8.04IU/L)和孕妇(23.88±8.66IU/L)的 ADA 活性明显高于正常非妊娠个体(11.85±3.23IU/L)(P<0.0001),但与 GDM 和正常孕妇相比,ADA 水平无显著差异(P=0.97)。
本研究中,GDM 和孕妇的 ADA 活性明显高于正常组。该领域的先前报告存在争议;因此,ADA 活性可能受到免疫和遗传因素的影响而在不同人群中进行调节。